Breast Reconstruction Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Technology, Type, Placement, and Procedure,” the market is expected to reach US$ 945.27 million by 2028 from US$ 593.61 million in 2020; it is estimated to grow at a CAGR of 6.1% from 2021 to 2028.
Breast cancer is one of the most common types of cancer observed among women. It is majorly characterized by the development of lumps in breasts, inversion of nipples, change in breast shape, release of fluids from nipples, red or scaly patches on skin, dimpling of the skin, and pain and soaring of nipples. Breast cancer is treated using mastectomy, a procedure that includes removal of entire breast through a surgical process. Breast reconstruction surgeries are used to rebuild the breasts after mastectomy. Implant reconstruction and autologous or flap reconstruction are the two main techniques used in these surgeries.
Get Sample Copy Of This [email protected] https://www.theinsightpartners.com/sample/TIPHE100001298/
Leading players operating in the breast reconstruction market adopt various growth strategies, such as product launches, approvals, partnerships, and business planning. These strategies help them expand their business in the global market. The market majorly consists of the players such as Allergan Plc, Mentor Worldwide LLC (Subsidiary of Johnson & Johnson), Sientra Inc., GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, HANSBIOMED CO. LTD., IDEAL IMPLANT INCORPORATED, Guangzhou Wanhe Plastic Materials Co., Ltd., Establishment Labs S.A., and Groupe Sebbin SAS.
Companies such as Allergan Plc, Mentor Worldwide LLC (Subsidiary of Johnson & Johnson), Sientra Inc., GC Aesthetics PLC, and POLYTECH Health & Aesthetics GmbH have been implementing various strategies that have propelled the growth of the company, which, in turn, have brought various changes in the breast reconstruction market .
Breast reconstruction is the surgical process of rebuilding the shape and look of a breast, most commonly in women who have had surgery to treat breast cancer. It involves using autologous tissue, prosthetic implants, or a combination of both with the goal of reconstructing a natural-looking breast.
With the increasing prevalence of breast cancer worldwide, many women are opting for reconstruction procedures to regain the original shape of their breasts after the mastectomy. According to breastcancer.org, as of January 2018, over 3.1 million women in the US had a history of breast cancer, including those who were undergoing a treatment and those who had undergone treatments in the past. Further, according to a study published by the World Health Organization (WHO), ~2.3 million women across the world were newly diagnosed with breast cancer in 2020.
Similarly, according to the breastcancercare.org.uk, the UK had ~691,000 women diagnosed with breast cancer and this number is estimated to reach 840,000 by 2020. Similar trends of rise in number of breast cancer cases have been observed in other parts of the world. The increasing prevalence of breast cancer, coupled with the growing preference for breast reconstruction procedures post mastectomy, is bolstering the market growth.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
The Insight Partners,
Email: [email protected]